Existing studies indicate that F. nucleatum can enhance the efficacy of pMMR CRC immunotherapy, primarily due to its ability to simultaneously boost the activity of immune cells, such as CD8+ T cells and CD34+ cells [95, 97, 98]. Here, CD8A is linked to colorectal carcinoma.